Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, July 29, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
ChromaTrap Receives Positive Commentary in Cited Research
Thursday, March 20, 2014
Researchers cite how using the fast, sensitive ChIP technology has benefited their research.

Telstar Provides Safety Cabinets to NUI Galway’s Biomedical Research Facility
Wednesday, March 19, 2014
The new, recently inaugurated research facility, which is directed towards cancer research, regenerative medicine and glycosciences, takes its place as one of five global hubs in the medtech sector.

Molecular Devices to Showcase Next Generation SpectraMax® MiniMax™ 300 Imaging Cytometer at Analytica
Wednesday, March 19, 2014
SpectraMax® MiniMax™ 300 imaging cytometer enables both cellular visualization and first-of-its-kind stain free cell-based analysis on the field-upgradable SpectraMax®i3 Multi-Mode Microplate Reader.

Advancing CRISPR Research with gBlocks Gene Fragments
Tuesday, March 18, 2014
Sequence and application flexibility allow for the exploration of CRISPR and Cas9 function.

GE Healthcare Launches High Performance Amersham™ Imager 600 Series
Monday, March 17, 2014
Superb imaging in chemiluminescence, fluorescence and colorimetric applications.

TATAA and MultiD Launch GenEx 6
Saturday, March 15, 2014
The software most compliant with guidelines for the analysis of real-time PCR data.

Double O-ring Ensures High Integrity Cap Mat Seal
Thursday, March 13, 2014
New silicone cap mats from Porvair Sciences.

OGT and Emory Genetics Laboratory Develop New Molecular Arrays
Wednesday, March 12, 2014
Emory’s Professor Madhuri Hegde to discuss OGT’s new molecular arrays at ACMG 2014.

IDT Reduces Undesirable Effects of RNAi Protocols
Wednesday, March 12, 2014
Learn about the latest advances at the Aptamers and RNAi conferences in Oxford, UK.

<< 6 7 8 9 10 11 12 >>
Showing Results 81 - 90 of 2496
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv